Research and development expenses were $37,300,000 for the Q1, which represents a $5,400,000 increase over the same period last year and $600,000 sequentially, approximately $600,000 Year over year, the increase includes $3,200,000 in increased salary costs within North America and $800,000 increased salary costs internationally. ITCs for the quarter were $3,800,000 compared to credits of $3,400,000 in the prior year Q1 last year. Foreign exchange for the Q1 was a gain of less than $100,000 compared to a foreign exchange loss of $2,100,000 in the Q1 last year. Looking at liquidity of the company, cash as at July 31, 2024 was $91,000,000 as compared to cash of $86,400,000 as of April 30, 2024. Working capital was $197,700,000 as of July 31, 2024 compared to $201,400,000 at the end of April 30, 2024.